Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 19, 2026 deadline to file a lead plaintiff motion in the class action...
-
BRUSSELS, April 02, 2026 (GLOBE NEWSWIRE) -- The European Commission’s newly released evaluation of the Tobacco Products Directive (TPD) is facing sharp criticism from the World Vapers’ Alliance...
-
Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing...
-
AUSTIN, Texas, April 02, 2026 (GLOBE NEWSWIRE) -- Momentum Cyber, the only investment bank exclusively focused on cybersecurity, today released its Q1 2026 Cybersecurity Market Review. The report...
-
LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises HelloFresh SE, (“HelloFresh" or the "Company") (OTCMKTS:HELFY) investors that the firm has initiated an investigation...
-
LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises America’s Car-Mart, Inc., (“Car-Mart" or the "Company") (NASDAQ:CRMT) investors that the firm has initiated an...
-
LOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises America’s Car-Mart, Inc., (“Car-Mart" or the "Company") (NASDAQ:CRMT) investors that the firm has initiated an...
-
Phase 1 study of INCA33890 and muzastotug expected to begin in 2026 in 3L MSS CRC patients with and without liver metastases Study will be sponsored and conducted by Incyte; Adagene to provide...
-
Dose-Dependent Efficacy Results: As of the latest data cut, muzastotug achieved a 31% (8/26) confirmed overall response rate (ORR) in the combined 20 mg/kg dose cohorts, showing a clear improvement...
-
LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Brown & Brown, Inc. (“Brown & Brown" or the "Company") (NYSE:BRO) investors that the firm has initiated an...